JNCCN 360

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Karl D. Lewis, MD, on Selecting Patients for Treatment With Cemiplimab-rwlc

Karl D. Lewis, MD, on the Role of Adjuvant Immunotherapy in NMSC

Theresa M. Medina, MD, on Basal Cell Carcinoma and Immunotherapy

Recent

SITC 2019: Using Activated Natural Killer Cells to Treat Merkel Cell Carcinoma

Vismodegib Discontinuation and Survival in Locally Advanced Basal Cell Carcinoma

Rare Cases of Perianal and Perineal Keratoacanthomas Reported

Advanced Non-Melanoma Skin Cancer: Systemic Treatment Update

Published

Medical Literature

Potential Link Between Kidney Disease and Increased Risk for Cutaneous Squamous Cell Carcinoma

Indoor Tanning: Increased Risk for Cutaneous Squamous Cell Carcinoma?

Do Individuals With Psoriasis Have an Increased Risk of Keratinocyte Cancers?

Cancer-Testis Antigens: Immunotherapy Targets for Merkel Cell Carcinoma?

Ongoing

New Treatments, New Data! Focus on Cutaneous Squamous Cell Carcinoma (login required)

Dermatologic Oncology Update, Issue 1, 2018

How to Effectively Manage Patients With Cutaneous Squamous Cell Carcinoma: Live From ASCO (login required)

Immunotherapy for cSCC: How, Why, and When (login required)

Available

Clinical Trials

University of Nebraska

Helen Diller Family Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

University of Wisconsin Carbone Cancer Center

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.